Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 3 3Phase 2 2Phase 1/2 2Phase 2/3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1CNS 1

Conditions

Sexual Infantilism 1Polycystic Ovary Syndrome 1Overweight 1Obesity 1Insulin Resistance 1Craniopharyngioma 1

Interventions

Cisplatin 1038Cyclophosphamide 972Carboplatin 952Radiotherapy 890Bevacizumab 845Gemcitabine 817pembrolizumab 758Paclitaxel 738Docetaxel 733Oxaliplatin 704Capecitabine 646Fluorouracil 563Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 400Leucovorin 376Cytarabine 342Cetuximab 338Lenalidomide 326Trastuzumab 321Pemetrexed 314durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 277Temozolomide 275Prednisone 273

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Exenatide × Clear all
NCT01484873 2017-03-03

Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor

Vanderbilt University Medical Center

Phase 2 Completed
10 enrolled 15 charts
CNSOther

Craniopharyngioma, Obesity, Sexual Infantilism, Overweight

NCT00344851 2007-07-11

Exenatide and Metformin Therapy in Overweight Women With PCOS

Metabolic Center of Louisiana Research Foundation

Phase 2 Completed
60 enrolled

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡